Fuhrman Alan
Insider CIK 1303521 · AMBI Chief Financial Officer · ESPR Director · MIRN Chief Financial Officer · LOXO Director · CMPI See Remarks, Director · SWTX Director · TYRA Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TYRA Tyra Biosciences, Inc. | A Award | 2026-09-15 | 2026-09-17 | 951 | $9.13 | $8.7K | 37,115 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award | 2026-09-15 | 2026-09-17 | 951 | $9.13 | $8.7K | 37,115 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2026-05-05 | 2026-05-07 | 67,000 | — | $0 | 67,000 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award | 2026-05-05 | 2026-05-07 | 20,000 | — | $0 | 36,164 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award | 2026-03-13 | 2026-03-17 | 1,376 | $9.13 | $12.6K | 16,164 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award | 2025-09-15 | 2025-09-17 | 701 | $9.13 | $6.4K | 14,788 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2025-08-07 | 2025-08-07 | 170,000 | — | $0 | 170,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 13,774 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 12,216 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 29,983 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 7,464 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 15,318 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer | 2025-07-01 | 2025-07-02 | 24,727 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2025-05-14 | 2025-05-15 | 10,060 | — | $0 | 24,727 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award | 2025-03-14 | 2025-03-18 | 1,238 | $9.78 | $12.1K | 14,087 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | P Buy | 2024-10-30 | 2024-11-01 | 9,500 | $16.00 | $152.0K | 12,849 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award | 2024-09-13 | 2024-09-17 | 954 | $12.48 | $11.9K | 3,349 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2024-08-14 | 2024-08-16 | 115,000 | — | $0 | 115,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2024-05-23 | 2024-05-24 | 32,500 | — | $0 | 32,500 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2024-05-23 | 2024-05-24 | 23,000 | — | $0 | 53,404 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2024-05-16 | 2024-05-17 | 12,216 | — | $0 | 12,216 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2024-05-16 | 2024-05-17 | 4,095 | — | $0 | 14,667 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award | 2024-03-15 | 2024-03-19 | 932 | $12.48 | $11.6K | 2,395 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award | 2023-09-15 | 2023-09-19 | 1,463 | $12.50 | $18.3K | 1,463 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2023-07-28 | 2023-08-01 | 62,685 | — | $0 | 62,685 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2023-06-15 | 2023-06-16 | 21,000 | — | $0 | 21,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2023-06-15 | 2023-06-16 | 5,150 | — | $0 | 30,404 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2023-05-24 | 2023-05-25 | 13,774 | — | $0 | 13,774 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2023-05-24 | 2023-05-25 | 4,648 | — | $0 | 10,572 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2023-01-01 | 2023-01-03 | 328,000 | — | $0 | 328,000 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2023-01-01 | 2023-01-03 | 32,800 | — | $0 | 32,800 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | D To issuer deriv | 2022-05-31 | 2022-05-31 | 22,736 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | D To issuer deriv | 2022-05-31 | 2022-05-31 | 246,671 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | D To issuer deriv | 2022-05-31 | 2022-05-31 | 10,030 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2022-05-26 | 2022-05-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2022-05-19 | 2022-05-20 | 15,318 | — | $0 | 15,318 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2022-05-19 | 2022-05-20 | 4,818 | — | $0 | 5,924 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | A Award deriv | 2021-10-27 | 2021-10-29 | 246,671 | — | $0 | 246,671 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | A Award deriv | 2021-06-16 | 2021-06-21 | 10,030 | — | $0 | 10,030 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2021-05-27 | 2021-05-28 | 12,376 | — | $0 | 25,254 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2021-05-20 | 2021-05-21 | 6,998 | — | $0 | 6,998 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2021-05-20 | 2021-05-21 | 1,106 | — | $0 | 25,227 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2020-05-28 | 2020-05-29 | 1,221 | — | $0 | 12,878 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2020-05-20 | 2020-05-22 | 7,464 | — | $0 | 7,464 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2020-05-15 | 2020-05-18 | 11,003 | — | $0 | 11,657 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2019-09-12 | 2019-09-16 | 29,983 | — | $0 | 29,983 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 13,000 | $235.00 | $3.06M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 8,750 | $235.00 | $2.06M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 11,000 | $235.00 | $2.58M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 7,812 | $235.00 | $1.84M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 7,812 | $235.00 | $1.84M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2018-06-13 | 2018-06-14 | 8,750 | — | $0 | 8,750 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise deriv | 2018-06-08 | 2018-06-11 | 2,625 | — | $0 | 13,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-06-08 | 2018-06-11 | 2,625 | $178.07 | $467.4K | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise | 2018-06-08 | 2018-06-11 | 2,625 | $11.35 | $29.8K | 2,625 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2017-06-22 | 2017-06-23 | 11,000 | — | $0 | 11,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2016-06-10 | 2016-06-13 | 7,812 | — | $0 | 7,812 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | A Award deriv | 2016-03-11 | 2016-03-14 | 60,000 | — | $0 | 60,000 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | A Award deriv | 2015-09-30 | 2015-09-30 | 167,180 | — | $0 | 167,180 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2015-07-28 | 2015-07-30 | 7,812 | — | $0 | 7,812 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2015-01-12 | 2015-01-14 | 15,625 | — | $0 | 15,625 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | D To issuer deriv | 2014-11-10 | 2014-11-12 | 68,369 | $3.19 | $218.1K | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | D To issuer deriv | 2014-11-10 | 2014-11-12 | 45,000 | $4.20 | $189.0K | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | D To issuer deriv | 2014-11-10 | 2014-11-12 | 27,517 | $15.00 | $412.8K | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | D To issuer deriv | 2014-11-10 | 2014-11-12 | 100,277 | $9.00 | $902.5K | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | D To issuer | 2014-11-10 | 2014-11-12 | 6,309 | $15.00 | $94.6K | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | A Award deriv | 2014-05-15 | 2014-05-19 | 27,517 | — | $0 | 27,517 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | A Award deriv | 2014-01-08 | 2014-01-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | A Award deriv | 2013-07-16 | 2013-07-18 | 68,369 | — | $0 | 68,369 | SEC↗ |